138 related articles for article (PubMed ID: 29703155)
1. Determinants of CD4 cell count change and time-to default from HAART; a comparison of separate and joint models.
Tegegne AS; Ndlovu P; Zewotir T
BMC Infect Dis; 2018 Apr; 18(1):197. PubMed ID: 29703155
[TBL] [Abstract][Full Text] [Related]
2. Joint longitudinal data analysis in detecting determinants of CD4 cell count change and adherence to highly active antiretroviral therapy at Felege Hiwot Teaching and Specialized Hospital, North-west Ethiopia (Amhara Region).
Seyoum A; Ndlovu P; Temesgen Z
AIDS Res Ther; 2017 Mar; 14(1):14. PubMed ID: 28302125
[TBL] [Abstract][Full Text] [Related]
3. Predictors of non-adherence to medication and time to default from treatment on HIV infected patients under HAART: a comparison of joint and separate models.
Abebe KB; Tegegne AS
Afr Health Sci; 2022 Mar; 22(1):443-455. PubMed ID: 36032467
[TBL] [Abstract][Full Text] [Related]
4. Factors affecting first month adherence due to antiretroviral therapy among HIV-positive adults at Felege Hiwot Teaching and Specialized Hospital, north-western Ethiopia; a prospective study.
Tegegne AS; Ndlovu P; Zewotir T
BMC Infect Dis; 2018 Feb; 18(1):83. PubMed ID: 29458343
[TBL] [Abstract][Full Text] [Related]
5. Predictors for CD4 cell count and hemoglobin level with survival time to default for HIV positive adults under ART treatment at University of Gondar Comprehensive and Specialized Hospital, Ethiopia.
Muhie NS; Tegegne AS
BMC Res Notes; 2023 Dec; 16(1):357. PubMed ID: 38042846
[TBL] [Abstract][Full Text] [Related]
6. Quasi-Poisson versus negative binomial regression models in identifying factors affecting initial CD4 cell count change due to antiretroviral therapy administered to HIV-positive adults in North-West Ethiopia (Amhara region).
Seyoum A; Ndlovu P; Zewotir T
AIDS Res Ther; 2016; 13():36. PubMed ID: 27843481
[TBL] [Abstract][Full Text] [Related]
7. Predictors of CD4 count over time among HIV patients initiated ART in Felege Hiwot Referral Hospital, northwest Ethiopia: multilevel analysis.
Gezie LD
BMC Res Notes; 2016 Jul; 9():377. PubMed ID: 27475982
[TBL] [Abstract][Full Text] [Related]
8. Determinants of hemoglobin level and time to default from Highly Active Antiretroviral Therapy (HAART) for adult clients living with HIV under treatment; a retrospective cohort study design.
Muhie NS; Tegegne AS
Sci Rep; 2024 Jun; 14(1):14929. PubMed ID: 38942753
[TBL] [Abstract][Full Text] [Related]
9. Treatment default among patients initiating HAART at the Korle-Bu Teaching Hospital in Accra, Ghana.
Wilhelm AK; Paci G; Lartey M; Kwara A
West Afr J Med; 2012; 31(4):264-9. PubMed ID: 23468030
[TBL] [Abstract][Full Text] [Related]
10. Joint Modeling in Detecting Predictors of CD4 Cell Count and Status of Tuberculosis Among People Living with HIV/AIDS Under HAART at Felege Hiwot Teaching and Specialized Hospital, North-West Ethiopia.
Bayabil S; Seyoum A
HIV AIDS (Auckl); 2021; 13():527-537. PubMed ID: 34040450
[TBL] [Abstract][Full Text] [Related]
11. Multilevel model on longitudinal data analysis in determinants of CD4 cell count among antiretroviral therapy attendant of HIV infected adults follow up in Gondar Teaching Referral Hospital, Gonder, Ethiopia.
Kebede K
AIDS Res Ther; 2021 Jan; 18(1):5. PubMed ID: 33451347
[TBL] [Abstract][Full Text] [Related]
12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
13. The Factors Related to CD4+ T-Cell Recovery and Viral Suppression in Patients Who Have Low CD4+ T Cell Counts at the Initiation of HAART: A Retrospective Study of the National HIV Treatment Sub-Database of Zhejiang Province, China, 2014.
He L; Pan X; Dou Z; Huang P; Zhou X; Peng Z; Zheng J; Zhang J; Yang J; Xu Y; Jiang J; Chen L; Jiang J; Wang N
PLoS One; 2016; 11(2):e0148915. PubMed ID: 26900702
[TBL] [Abstract][Full Text] [Related]
14. Criteria for initiating highly active antiretroviral therapy and short-term immune response among HIV-1-infected patients in Côte d'Ivoire.
Diabaté S; Alary M
HIV Med; 2009 Nov; 10(10):640-6. PubMed ID: 19659945
[TBL] [Abstract][Full Text] [Related]
15. Determinants of change in CD4 count and relationship with survival among children with HIV in Ethiopia.
Nigusie T; Asfaw D; Belete B
AIDS Care; 2021 Sep; 33(9):1237-1241. PubMed ID: 32689807
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy.
Sterling TR; Chaisson RE; Moore RD
AIDS; 2001 Nov; 15(17):2251-7. PubMed ID: 11698698
[TBL] [Abstract][Full Text] [Related]
17. Determinants of CD4 count and risk for death of HIV infected children under ART.
Gwadu AA; Tegegne AS
Sci Rep; 2022 Apr; 12(1):6867. PubMed ID: 35477950
[TBL] [Abstract][Full Text] [Related]
18. Predictive effects of body mass index on immune reconstitution among HIV-infected HAART users in China.
Li X; Ding H; Geng W; Liu J; Jiang Y; Xu J; Zhang Z; Shang H
BMC Infect Dis; 2019 May; 19(1):373. PubMed ID: 31046702
[TBL] [Abstract][Full Text] [Related]
19. Time to immunologic recovery and determinant factors among adults who initiated ART in Felege Hiwot Referral Hospital, northwest Ethiopia.
Gezie LD; Gelaye KA; Worku AG; Ayele TA; Teshome DF
BMC Res Notes; 2017 Jul; 10(1):277. PubMed ID: 28705176
[TBL] [Abstract][Full Text] [Related]
20. Joint modelling of longitudinal and time-to-event data: an illustration using CD4 count and mortality in a cohort of patients initiated on antiretroviral therapy.
Mchunu NN; Mwambi HG; Reddy T; Yende-Zuma N; Naidoo K
BMC Infect Dis; 2020 Mar; 20(1):256. PubMed ID: 32228483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
